Cantor Fitzgerald Forecasts Nano-X Imaging FY2025 Earnings

Nano-X Imaging Ltd. (NASDAQ:NNOX) – Analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for shares of Nano-X Imaging in a research note issued to investors on Tuesday, April 1st. Cantor Fitzgerald analyst R. Osborn now forecasts that the company will post earnings per share of ($0.71) for the year, down from their previous estimate of ($0.61). Cantor Fitzgerald has a “Overweight” rating and a $9.00 price target on the stock. The consensus estimate for Nano-X Imaging’s current full-year earnings is ($0.92) per share.

Separately, D. Boral Capital reissued a “buy” rating and issued a $15.00 price target on shares of Nano-X Imaging in a report on Monday.

Nano-X Imaging Stock Performance

Shares of NNOX opened at $4.67 on Thursday. The stock has a market capitalization of $269.83 million, a price-to-earnings ratio of -5.49 and a beta of 1.99. Nano-X Imaging has a 52-week low of $4.58 and a 52-week high of $11.39. The stock’s 50-day simple moving average is $6.32 and its 200 day simple moving average is $6.61.

Nano-X Imaging (NASDAQ:NNOX) last posted its quarterly earnings results on Monday, March 31st. The company reported ($0.23) EPS for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.08). The company had revenue of $3.00 million during the quarter, compared to the consensus estimate of $3.80 million. Nano-X Imaging had a negative return on equity of 27.63% and a negative net margin of 465.38%.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in NNOX. US Bancorp DE raised its position in shares of Nano-X Imaging by 388.7% in the fourth quarter. US Bancorp DE now owns 3,470 shares of the company’s stock worth $25,000 after buying an additional 2,760 shares in the last quarter. Quadrant Capital Group LLC raised its holdings in shares of Nano-X Imaging by 464.9% in the 4th quarter. Quadrant Capital Group LLC now owns 7,016 shares of the company’s stock valued at $51,000 after acquiring an additional 5,774 shares in the last quarter. Quantum Private Wealth LLC bought a new stake in shares of Nano-X Imaging during the 4th quarter valued at about $72,000. Signaturefd LLC grew its holdings in shares of Nano-X Imaging by 164.6% during the fourth quarter. Signaturefd LLC now owns 10,391 shares of the company’s stock worth $75,000 after purchasing an additional 6,464 shares in the last quarter. Finally, PharVision Advisers LLC bought a new position in shares of Nano-X Imaging in the fourth quarter worth approximately $80,000. 21.49% of the stock is currently owned by hedge funds and other institutional investors.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.